Concepedia

Publication | Open Access

The Novel Methylation Biomarker SCARA5 Sensitizes Cancer Cells to DNA Damage Chemotherapy Drugs in NSCLC

14

Citations

32

References

2021

Year

Abstract

SCARA5 was silenced in NSCLC due to promoter methylation and could be a potential tumor marker in NSCLC.

References

YearCitations

Page 1